NCT02128308View on ClinicalTrials.gov

Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Healthy
Interventions
DRUG

Levofloxacin and Streptomycin added

DRUG

Moxifloxacin and Kanamycin added

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02128308 - Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents | Biotech Hunter | Biotech Hunter